Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/19884622

Ann. Intern. Med. 2009 Nov 3 151 9 612-21

Download in:

View as

Triples

General Info

PMID
19884622